Publication | Closed Access

Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years

Surgical OncologyUrologyGenitourinary CancerMedicineMedian Follow-upNonmetastatic Prostate Cancer150-Mg MonotherapyProstatic DiseaseOncologyRadiation Oncology